- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Punjab Bans 112 Substandard Drugs After CDSCO Warning

Punjab: In a decisive move to safeguard public health, the Punjab Government has banned the sale of 112 medicines declared "substandard" by the Central Drugs Standard Control Organisation (CDSCO). The action follows several recent incidents in which the consumption of certain drugs reportedly led to fatalities.
Earlier, the Medical Dialogues Team reported that the Central Drugs Standard Control Organization (CDSCO) identified 112 batches of medicines and medical products as "Not of Standard Quality" (NSQ) after samples tested in September 2025 by its central and state laboratories failed to meet required pharmacopeial and safety standards.
The flagged products cover a wide range of therapeutic categories, including antibiotics, analgesics, antipyretics, antidiabetics, and other essential medicines.
These include Glimepiride Tablets IP 1 mg, manufactured by Karnataka Antibiotics and Pharmaceuticals; Telmisartan tab I.P. 40 mg, manufactured by Helax Healthcare, Bromhexine Hydrochloride Tablets IP 4 mg, manufactured by J.P. Industries; Rabeprazole Sodium Injection IP, manufactured by Martin & Brown Bio-Sciences, Dexamethasone Injection I.P., manufactured by SGS Pharmaceuticals, Pantoprazole Tablets I.P,. manufactured by Healers Lab, Cefixime Tablets IP 200 mg, manufactured by SVR Healthcare, and others.
The list further includes Diclofenac Sodium and Paracetamol Tablets IP manufactured by Zydus Healthcare, Clobetasol Propionate Neomycin Sulfate and Miconazole Nitrate Cream manufactured by Macleods Pharmaceuticals, Ivabradine Tablets 5 mg manufactured by Hetero Labs.
Following this, the Punjab Government has imposed a strict ban on the sale of substandard medicines.
Balbir Singh, the state’s Health Minister, revealed the move in a social media message posted on Sunday, saying;
"Following a report from the CDSCO declaring these drugs to be of poor quality, the Health Department has ordered their immediate removal from the market. Citizens are advised to avoid using any of the listed medicines. Ensuring the health and safety of every resident remains the top priority of the Mann Government."
The Punjab Government has imposed a strict ban on the sale of substandard medicines. Following a report from the CDSCO declaring these drugs to be of poor quality, the Health Department has ordered their immediate removal from the market. Citizens are advised to avoid using any… pic.twitter.com/L4ziRSxIdl
— Dr Balbir Singh (@AAPbalbir) October 26, 2025
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

